SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003785
Filing Date
2017-05-08
Accepted
2017-05-08 16:10:14
Documents
96
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20170331x10q.htm 10-Q 2060728
2 EX-10.1 irwd-20170331ex101cbd3ab.htm EX-10.1 132692
3 EX-10.2 irwd-20170331ex102005a26.htm EX-10.2 406591
4 EX-10.3 irwd-20170331ex10346483e.htm EX-10.3 138902
5 EX-31.1 irwd-20170331ex31136a293.htm EX-31.1 18743
6 EX-31.2 irwd-20170331ex3125db97b.htm EX-31.2 18692
7 EX-32.1 irwd-20170331ex321e3156c.htm EX-32.1 8520
8 EX-32.2 irwd-20170331ex322dbae39.htm EX-32.2 8656
  Complete submission text file 0001558370-17-003785.txt   9794043

Data Files

Seq Description Document Type Size
9 EX-101.INS irwd-20170331.xml EX-101.INS 1938953
10 EX-101.SCH irwd-20170331.xsd EX-101.SCH 73501
11 EX-101.CAL irwd-20170331_cal.xml EX-101.CAL 80748
12 EX-101.DEF irwd-20170331_def.xml EX-101.DEF 407037
13 EX-101.LAB irwd-20170331_lab.xml EX-101.LAB 610852
14 EX-101.PRE irwd-20170331_pre.xml EX-101.PRE 607483
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 17822298
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences